David S. Kinard - 01 Mar 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Executive Vice President, Human Resources, Corporate Affairs and Administration
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard
Issuer symbol: ELAN
Transactions as of: 01 Mar 2026
Net transactions value: -$405,953
Form type: 4
Filing time: 03 Mar 2026, 19:16:44 UTC
Previous filing: 05 Mar 2025
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kinard David S	Executive Vice President, Human Resources, Corporate Affairs and Administration	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard	03 Mar 2026	0001752439

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Award	$0	+33,087	+17%	$0.000000	223,604	01 Mar 2026	Direct	F1
transaction	ELAN	Common Stock	Tax liability	$405,953	-15,377	-6.9%	$26.40	208,227	01 Mar 2026	Direct
transaction	ELAN	Common Stock	Award	$0	+9,470	+4.5%	$0.000000	217,697	01 Mar 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Employee Stock Option (right to buy)	Award	$0	+19,350		$0.000000	19,350	01 Mar 2026	Common Stock	19,350	$26.40	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 648 shares acquired on April 30, 2025, 518 shares acquired on July 31, 2025, 221 shares acquired on October 31, 2025, and 252 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .
F2	Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
F3	Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

Remarks:

Executive Vice President, Human Resources, Corporate Affairs and Administration